Compounds > vatalanib
Page last updated: 2024-09-04

vatalanib and dichlororibofuranosylbenzimidazole

vatalanib has been researched along with dichlororibofuranosylbenzimidazole in 1 studies

Compound Research Comparison

Studies
(vatalanib)		Trials
(vatalanib)		Recent Studies (post-2010)
(vatalanib)		Studies
(dichlororibofuranosylbenzimidazole)		Trials
(dichlororibofuranosylbenzimidazole)		Recent Studies (post-2010) (dichlororibofuranosylbenzimidazole)
2764298528264

Protein Interaction Comparison

ProteinTaxonomyvatalanib (IC50)dichlororibofuranosylbenzimidazole (IC50)
Chain A, Cell division protein kinase 9Homo sapiens (human)34.29
Chain A, Cell division protein kinase 2Homo sapiens (human)34.29

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Bullock, AN; Fedorov, O; Knapp, S; Marsden, B; Müller, S; Pogacic, V; Rellos, P; Schwaller, J; Sundström, M1

Other Studies

1 other study(ies) available for vatalanib and dichlororibofuranosylbenzimidazole

ArticleYear
A systematic interaction map of validated kinase inhibitors with Ser/Thr kinases.
    Proceedings of the National Academy of Sciences of the United States of America, 2007, Dec-18, Volume: 104, Issue:51

    Topics: Amino Acid Sequence; Binding Sites; Clinical Trials as Topic; Drug Evaluation, Preclinical; Enzyme Stability; Humans; Molecular Sequence Data; Phylogeny; Protein Array Analysis; Protein Conformation; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases

2007